AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
Singular Genomics Systems Inc (NASDAQ:OMIC)
20 USD
+0.400 2.041%Sponsored Reports
Loading...
| Previous Close (in USD) | 19.6 |
|---|---|
| Change | +0.400 2.041% |
| 52 W H/L (in USD) | 1.060/0.310 |
| EBITDA (in USD) | -97.391M |
| PE Ratio | -- |
| Volume | 3093 |
| Diluted Eps TTM | -1.31 |
| Total Assets (in USD) | 265.467M |
|---|---|
| Total Liabilities (in USD) | 86.461M |
| Revenue TTM (in USD) | 2.911M |
| Cash (in USD) | 16.233M |
| Market Cap (in USD) | 28.229 M |
| Revenue Per Share TTM | 0.040 |
| Gross Profit TTM (in USD) | -0.024M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Singular Genomics Systems Inc
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.
3010 Science Park Road, San Diego, CA, United States, 92121
858 333 7830
Employees: 255
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Andrew Spaventa | Founder, CEO, Pres & Chairperson of the Board | 1985 |
| 2. | Dr. David L. Barker Ph.D. | Founder, Member of Scientific Advisory Board & Independent Director | 1942 |
| 3. | Ms. Daralyn Durie | Gen. Counsel | 1968 |
| 4. | Dr. Eli N. Glezer Ph.D. | Founder, Chief Scientific Officer & Chair of Scientific Advisory Board | 1969 |
| 5. | Mr. Dalen Meeter | Sr. VP of Fin. & CFO | 1978 |
| 6. | Mr. Jorge Velarde Jr., MBA | Sr. VP of Corp. Devel. & Strategy | 1967 |
| 7. | Mr. Jeff Bullard | Head of Sales | NA |
| 8. | Mr. Vincent Brancaccio | Sr. VP of HR | 1983 |
| 9. | Mr. Andrew Spaventa | Founder, CEO, President & Chairperson of the Board | 1985 |
| 10. | Mr. Dalen Meeter | Chief Financial Officer | 1978 |
Peers
Sector: Healthcare
Industry: Medical Instruments & Supplies
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ISRG
Intuitive Surgical Inc |
+3.110 0.591% | 532.735 | 73.050 | 61.728 | 19.145 | 10.247 | 18.408 | 59.920 |
|
ESLOY
Essilor International SA |
-0.640 0.532% | 120.15 | 35.390 | 24.814 | 3.630 | 2.204 | 3.996 | 16.255 |
|
ESLOF
EssilorLuxottica Société anonyme |
-3.500 1.437% | 240 | 35.710 | 25.126 | 3.623 | 2.229 | 3.995 | 16.251 |
|
BDX
Becton Dickinson and Company |
+1.060 0.473% | 223.33 | 37.720 | 15.924 | 3.252 | 2.490 | 4.085 | 17.104 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|
| Income Before Tax | -90.879M | -98.771M | -27.945M | -12.324M |
| Minority Interest | - | - | - | - |
| Net Income | -88.271M | -98.889M | -28.663M | -12.341M |
| Selling General Administrative | 47.264M | 28.624M | 6.287M | 2.286M |
| Gross Profit | -0.024M | - | - | - |
| Reconciled Depreciation | 6.032M | 1.133M | 0.639M | 0.35M |
| Ebit | -93.487M | -61.279M | -27.534M | -12.77M |
| Ebitda | -90.116M | -60.546M | -26.39M | -11.957M |
| Depreciation And Amortization | 3.371M | 0.733M | 1.144M | 0.813M |
| Operating Income | -93.487M | -61.279M | -27.534M | -12.77M |
| Other Operating Expenses | 94.252M | 61.279M | 27.534M | 12.77M |
| Interest Expense | 0.763M | 0.846M | 0.718M | 0.017M |
| Tax Provision | - | - | - | - |
| Interest Income | 3.371M | 0.328M | 0.505M | 0.463M |
| Net Interest Income | 2.608M | -0.518M | -0.213M | 0.446M |
| Income Tax Expense | -2.608M | 0.118M | 0.718M | 0.017M |
| Total Revenue | 0.765M | 0M | 0M | 0M |
| Total Operating Expenses | 93.463M | 61.279M | 27.534M | 12.77M |
| Cost Of Revenue | 0.789M | - | - | - |
| Total Other Income Expense Net | 2.608M | -37.492M | -0.411M | 0.446M |
| Net Income From Continuing Ops | -90.879M | -63.572M | -27.945M | -12.324M |
| Net Income Applicable To Common Shares | -90.879M | -98.771M | -27.945M | -12.324M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 265.467M | 327.975M | 355.648M | 30.502M | 48.174M |
| Intangible Assets | - | - | - | - | - |
| Other Current Assets | 1.459M | 4.722M | 4.476M | 0.652M | 0.261M |
| Total Liab | 86.461M | 67.654M | 19.475M | 82.057M | 72.899M |
| Total Stockholder Equity | 179.006M | 260.321M | 336.173M | -51.555M | -24.725M |
| Other Current Liab | 1.857M | 4.696M | 4.396M | 0.745M | 0.551M |
| Common Stock | 0.007M | 0.007M | 0.007M | 0.001M | 0.001M |
| Capital Stock | 0.007M | 0.007M | 0.007M | 0.001M | 0.001M |
| Retained Earnings | -337.595M | -242.775M | -151.896M | -53.125M | -25.18M |
| Good Will | - | - | - | - | - |
| Other Assets | - | 2.863M | 1.816M | 0.563M | 0.104M |
| Cash | 16.233M | 74.266M | 201.049M | 11.688M | 5.5M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 18.287M | 14.118M | 6.744M | 3.69M | 1.112M |
| Current Deferred Revenue | 6.079M | - | - | 1.592M | - |
| Net Debt | 59.055M | -15.422M | -191.145M | -2.293M | -3.1M |
| Short Term Debt | 7.764M | 6.323M | - | 0.926M | - |
| Short Long Term Debt | - | - | - | 0.926M | - |
| Short Long Term Debt Total | 75.288M | 58.844M | 9.904M | 9.395M | 2.4M |
| Other Stockholder Equity | 516.439M | 503.926M | 132.552M | 1.552M | 0.44M |
| Property Plant Equipment | - | 10.784M | 6.072M | 2.368M | 1.613M |
| Total Current Assets | 192.228M | 268.432M | 347.76M | 27.571M | 46.457M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | 157.708M | 170.31M | 138.174M | 15.231M | 40.696M |
| Net Receivables | 1.584M | 0.913M | 1.05M | 0.017M | - |
| Long Term Debt | 8.901M | 10.065M | 9.904M | 8.469M | 2.4M |
| Inventory | 13.572M | 18.221M | 3.011M | - | - |
| Accounts Payable | 2.587M | 3.099M | 2.348M | 0.427M | 0.561M |
| Accumulated Other Comprehensive Income | 0.155M | -0.837M | -0.138M | 0.017M | 0.014M |
| Non Currrent Assets Other | 1.75M | 2.863M | 1.816M | 0.563M | 0.104M |
| Non Current Assets Total | 73.239M | 59.543M | 7.888M | 2.931M | 1.717M |
| Capital Lease Obligations | 66.387M | 48.779M | - | - | - |
| Long Term Debt Total | - | 10.065M | 9.904M | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|
| Investments | -33.544M | -125.997M | 25.385M | -30.7M |
| Total Cashflows From Investing Activities | -39.566M | -130.861M | 24.005M | -31.5M |
| Total Cash From Financing Activities | 0.901M | 372.128M | 7.515M | 47.304M |
| Net Income | -90.879M | -98.771M | -27.945M | -12.324M |
| Change In Cash | -125.759M | 189.566M | 6.647M | 4.405M |
| Begin Period Cash Flow | 201.736M | 12.17M | 5.523M | 1.118M |
| End Period Cash Flow | 75.977M | 201.736M | 12.17M | 5.523M |
| Total Cash From Operating Activities | -87.094M | -51.701M | -24.873M | -11.399M |
| Depreciation | 6.032M | 1.133M | 0.639M | 0.35M |
| Other Cashflows From Investing Activities | - | - | - | - |
| Dividends Paid | - | 3.577M | - | - |
| Change To Inventory | -13.487M | -13.487M | -13.487M | -13.487M |
| Sale Purchase Of Stock | -0.45M | 3.577M | -0.03M | - |
| Other Cashflows From Financing Activities | 1.18M | 141.752M | 7.498M | 47.263M |
| Capital Expenditures | 6.022M | 4.864M | 1.38M | 0.8M |
| Change In Working Capital | -16.817M | -2.911M | 0.858M | 0.415M |
| Other Non Cash Items | 0.901M | 35.478M | 0.234M | -0.01M |
| Free Cash Flow | -93.116M | -56.565M | -26.253M | -12.199M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Vanguard Total Stock Mkt Idx Inv | 7 months ago | 1180133 |
| 2. | Vanguard Institutional Extnd Mkt Idx Tr | 7 months ago | 649099 |
| 3. | Fidelity Extended Market Index | 8 months ago | 247401 |
| 4. | BlackRock Advantage Small Cap Core Instl | 7 months ago | 130459 |
| 5. | iShares Micro-Cap ETF | 7 months ago | 121370 |
| 6. | Bridgeway Ultra-Small Company Market | 8 months ago | 107600 |
| 7. | Fidelity Total Market Index | 8 months ago | 78330 |
| 8. | Christopher Weil & Co Core Investment | 8 months ago | 66696 |
| 9. | Fidelity Series Total Market Index | 8 months ago | 59283 |
| 10. | NT Ext Equity Mkt Idx Fd - NL | 8 months ago | 38487 |
| 11. | NT Ext Equity Mkt Idx Fd - L | 8 months ago | 38201 |
| 12. | Northern Trust Extended Eq Market Idx | 8 months ago | 38201 |
| 13. | Fidelity Nasdaq Composite Index | 8 months ago | 37412 |
| 14. | JPMorgan Small Cap Sustainable Ldrs R5 | 8 months ago | 36852 |
| 15. | NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 11 months ago | 30910 |
| 16. | BlackRock Extended Mkt Composite | 1 year ago | 29725 |
| 17. | Vanguard Balanced Index Inv | 7 months ago | 26684 |
| 18. | Spartan Total Market Index Pool E | 8 months ago | 25980 |
| 19. | BlackRock Extended Equity Market K | 8 months ago | 25942 |
| 20. | LUX IM Global Medtech HX | 7 months ago | 18700 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | ARCH VENTURE CORP | 8 months ago | 3798926 |
| 2. | QVIDTVM Management LLC | 8 months ago | 2506695 |
| 3. | UBS Group AG | 11 months ago | 2209350 |
| 4. | Perceptive Advisors LLC | 8 months ago | 2126893 |
| 5. | FMR Inc | 11 months ago | 2119635 |
| 6. | Vanguard Group Inc | 8 months ago | 1872582 |
| 7. | Casdin Capital, LLC | 11 months ago | 1323885 |
| 8. | Bank of Montreal | 11 months ago | 982499 |
| 9. | BMO Capital Markets Corp. | 11 months ago | 982499 |
| 10. | BlackRock Inc | 11 months ago | 833595 |
| 11. | Orbimed Advisors, LLC | 8 months ago | 540697 |
| 12. | Verition Fund Managegment, LLC | 8 months ago | 500000 |
| 13. | Geode Capital Management, LLC | 11 months ago | 460639 |
| 14. | HighTower Advisors, LLC | 11 months ago | 418322 |
| 15. | Tikvah Management LLC | 8 months ago | 316854 |
| 16. | Hongkou Capital LP | 8 months ago | 194731 |
| 17. | Millennium Management LLC | 8 months ago | 176000 |
| 18. | Renaissance Technologies Corp | 11 months ago | 151450 |
| 19. | Weil Company Inc | 11 months ago | 138202 |
| 20. | Bridgeway Capital Management, LLC | 8 months ago | 121500 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Related Articles
Loading...
